Ito Y, Suzuki H, Hattori Y, Muhammad B A H, Takahashi T, Suzuki K, Kazui T
First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Transplant Proc. 2004 Oct;36(8):2406-12. doi: 10.1016/j.transproceed.2004.06.028.
Tracheal immunogenicity has been controversial. Although replacement of allotracheal epithelia by the host epithelia has been reported in rat orthotopic tracheal grafting, the immunological effect of epithelial replacement is still uncertain.
We performed orthotopic tracheal grafting of nine cartilage rings in the following groups: 1, Lewis --> Lewis (n = 30); 2, ACI --> DA (n = 25); 3, Lewis --> F344 (n = 23); 4-A, DA --> Lewis (n = 41); 4-B, DA --> Lewis with tacrolimus therapy (1 mg/kg/d for 10 days) starting from the day of the operation (n = 31); 4-C, retransplantation of DA allografts to secondary naive Lewis rats 10 or 15 days after primary grafting (n = 11); 4-D, DA --> Lewis with tacrolimus therapy starting from postoperative day 10 (n = 6). Survival times and histopathology were assessed. Epithelial replacement was evaluated by immunohistochemistry.
All rats survived in groups 1, 2, and 3. Even in the fully histoincompatible group 4-A, survival ratio on day 120 was 15%. Epithelial replacement was in progress on day 10 in this group. However, all tacrolimus-treated rats died by day 54 and epithelial replacement did not occur on days 30 and 50 in group 4-B. In group 4-C, retransplantation after complete epithelial replacement increased the long-surviving rats. In group 4-D, all rats receiving tacrolimus therapy after complete epithelial replacement survived over 120 days.
These results suggest that complete replacement of tracheal epithelia by the host promotes spontaneous acceptance of orthotopic tracheal allografts in rats.
气管的免疫原性一直存在争议。尽管在大鼠原位气管移植中已报道宿主上皮细胞可替代同种异体气管上皮细胞,但上皮替代的免疫效应仍不确定。
我们在以下几组中进行了九个软骨环的原位气管移植:1,Lewis→Lewis(n = 30);2,ACI→DA(n = 25);3,Lewis→F344(n = 23);4 - A,DA→Lewis(n = 41);4 - B,从手术当天开始给予他克莫司治疗(1 mg/kg/d,共10天)的DA→Lewis(n = 31);4 - C,在初次移植后10或15天将DA同种异体移植物再次移植到未接触过抗原的Lewis大鼠(n = 11);4 - D,从术后第10天开始给予他克莫司治疗的DA→Lewis(n = 6)。评估存活时间和组织病理学。通过免疫组织化学评估上皮替代情况。
第1、2和3组的所有大鼠均存活。即使在完全组织不相容的第4 - A组中,第120天的存活率也为15%。该组在第10天时上皮替代正在进行。然而,所有接受他克莫司治疗的大鼠在第54天时死亡,且第4 - B组在第30天和第50天时未发生上皮替代。在第4 - C组中,完全上皮替代后再次移植增加了长期存活的大鼠数量。在第4 - D组中,完全上皮替代后接受他克莫司治疗的所有大鼠存活超过120天。
这些结果表明宿主完全替代气管上皮可促进大鼠原位气管同种异体移植物的自发接受。